Navigation Links
Asymchem Laboratories Hires Three New Employees: Guojie Xu, Pingzhong Huang, and Xiaojun Huang
Date:4/23/2010

MORRISVILLE, N.C., April 23 /PRNewswire/ -- Asymchem Laboratories is proud to announce and welcome Dr. Guojie (George) Xu as Director of Formulation Development, Dr. Pingzhong Huang as Director of Chemical Development, and Dr. Xiaojun Huang as Senior Director of Chemical Development.

Dr. Guojie (George) Xu joined Asymchem on February 1, 2010.  He brings extensive scientific and managerial experience in pharmaceutical formulations to Asymchem.    Dr. Xu was most recently Product Development Manager at Sandoz, where he held roles of increasing responsibility over 10 year.  Educated in China, he went on to earn a Ph.D. in Pharmaceutics from Meijo University in Japan and held appointments at Shenyang Pharmaceutical University, Beijing Institute for Pharmacology & Toxicology, and the University of Chicago.  Dr. Xu splits his time between Asymchem's Morrisville, NC headquarters and Life Science Center in Tianjin, China.

Dr. Pingzhong Huang joined Asymchem on March 15, 2010.  He brings 15 years of experience in contract synthesis and pharmaceutical process chemistry to the job, most recently at Wyeth in Pearl River, New York where he was a Senior Research Scientist in the Chemical Sciences group.  Dr. Huang graduated from Peking University and earned a Ph.D. in synthetic organic chemistry at the University of Geneva.  Dr. Huang splits his time between Asymchem's Morrisville, NC headquarters and Life Science Center in Tianjin, China.

Dr. Xiaojun Huang will be joining Asymchem on April 26, 2010.  Dr. Huang has previous experience at Roche, where he was a research scientist in Palo Alto, California, and Pfizer in La Jolla, California.  He has degrees in chemistry from Fudan University in Shanghai and the University of Edmonton and also held a postdoctoral appointment at Stanford University with Barry Trost. Dr. Huang will be based at Asymchem's Life Science Center in Tianjin, China.

Asymchem Laboratories is a leading research-based contract manufacturer specializing in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 15 yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena.  For further information, please visit the Asymchem website at www.asymchem.com or contact Leigh-Anne Ronk at 919-468-3884.

               


'/>"/>
SOURCE Asymchem Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Three Steps to Boost Asymchems Investment in China
2. Pfizer Global R&D Presents 2008 Top Intermediates CMO Award to Asymchem
3. Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development
4. Codexis Appoints Singapore Laboratories Managing Director
5. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
8. Stiefel Laboratories Appoints Two New Members to Board of Directors
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
10. ARUP Laboratories Releases ARUP Consult(R) 2.0
11. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 Research and Markets has announced ... Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, ... ... global market is projected to reach $15,737 million by 2022 from ... to 2022. Omic technologies segment accounted for more ...
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... Berkeley, CA (PRWEB) , ... January 19, 2017 ... ... the delivery of product vigilance software to leading biopharmaceutical and medical device manufacturers ... Mail is a fully 21 CFR Part 11-compliant email client designed to provide ...
(Date:1/19/2017)... , Jan. 19, 2017 AquaBounty Technologies, ... on enhancing productivity in aquaculture and a majority-owned subsidiary ... that it has completed the listing of its common ... equity subscription from Intrexon. "AquaBounty,s listing on ... will broaden our exposure to the U.S. markets as ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much ... doors or starting the engine. Continental will demonstrate the ... Las Vegas . Through the combination of ... and Entry) and biometric elements, the international technology company ... vehicle personalization and authentication. "The integration of ...
(Date:12/8/2016)... Market Research Future published a half cooked research report ... Security and Service Market is expected to grow over the CAGR ... Highlights: ... Mobile Biometric Security and Service Market is ... of authentication and security from unwanted cyber threats. The increasing use ...
Breaking Biology News(10 mins):